An Eg5 inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

ARQ 621

Item No. 34329

Technical Information
Formal Name
N-(3-aminopropyl)-3-chloro-N-[(1R)-1-[7-chloro-3,4-dihydro-4-oxo-3-(phenylamino)-2-quinazolinyl]-3-butyn-1-yl]-2-fluoro-benzamide
CAS Number
1095253-39-6
Molecular Formula
C28H24Cl2FN5O2
Formula Weight
Purity
≥98%
Formulation
A solid
λmax
239 nm
SMILES
O=C(C1=C(C(Cl)=CC=C1)F)N(CCCN)[C@@H](C(N2NC3=CC=CC=C3)=NC4=CC(Cl)=CC=C4C2=O)CC#C
InChi Code
InChI=1S/C28H24Cl2FN5O2/c1-2-8-24(35(16-7-15-32)27(37)21-11-6-12-22(30)25(21)31)26-33-23-17-18(29)13-14-20(23)28(38)36(26)34-19-9-4-3-5-10-19/h1,3-6,9-14,17,24,34H,7-8,15-16,32H2/t24-/m1/s1
InChi Key
UPJSUQWHUVLLNW-XMMPIXPASA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    ARQ 621 is an Eg5 inhibitor.1 It reduces tumor growth in a MIA PaCa-2 pancreatic cancer mouse xenograft model when administered at a dose of 6.25 mg/kg

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Jeay, S., Ali, S., Chen, C.-R., et alDiscovery of a novel Eg5 kinesin inhibitor, ARQ 621, with potent antitumor activity while sparing bone marrow-derived cells. Cancer Res. 68(9 Suppl.), 656 (2008).